APA (7th ed.) Citation

D, C., S, K., G, F., N, T., & O, S. (2023). Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosis. CEN case reports, 12(1), 27. https://doi.org/10.1007/s13730-022-00711-4

Chicago Style (17th ed.) Citation

D, Chan, Karimi S, Follows G, Torpey N, and Suchanek O. "Use of Rituximab in SARS-CoV-2-positive Renal Transplant Recipient with EBV Reactivation and Probable Haemophagocytic Lymphohistiocytosis." CEN Case Reports 12, no. 1 (2023): 27. https://doi.org/10.1007/s13730-022-00711-4.

MLA (9th ed.) Citation

D, Chan, et al. "Use of Rituximab in SARS-CoV-2-positive Renal Transplant Recipient with EBV Reactivation and Probable Haemophagocytic Lymphohistiocytosis." CEN Case Reports, vol. 12, no. 1, 2023, p. 27, https://doi.org/10.1007/s13730-022-00711-4.